HealthTech Monetisation in India: The Models That Actually Work

Why Consumer Health Subscription Is Hard in India

The willingness-to-pay reality for Indian consumer health apps is sobering. In a market where healthcare is either heavily subsidised (government hospitals), negotiated intensely (OPD consultations haggled down), or covered by employer insurance (for the formal workforce), asking consumers to pay a monthly subscription for health access faces deep structural resistance. Users who pay ₹499/month for Spotify or Netflix feel differently about paying ₹499/month for a health app — entertainment delivers reliable, predictable value; health apps often feel most valuable when you're unwell, which is intermittent and unpredictable.

The apps that have built successful consumer subscriptions (1mg, Healthians, Practo) did so by anchoring to transactional value — "you paid ₹X and saved ₹Y on lab tests this month" — rather than abstract health management benefits. Subscription works in Indian healthtech when users can see a concrete rupee saving versus the alternative in every billing period.

Model 1: B2B2C — The Most Scalable Path

The B2B2C model sells health access or wellness programs to an employer, insurance company, or government health scheme — who then provides it to their employees, members, or beneficiaries. The end user gets health services for free (or heavily subsidised). The business gets paid by the institutional buyer. This model has the most momentum in Indian healthtech right now because it solves the willingness-to-pay problem entirely.

The employer wellness model: Companies like Mfine, Eka Care, and Healthassure have built significant revenue by selling corporate wellness programs to HR departments. The typical package: unlimited teleconsultations + health checks + mental health support for ₹1,500-4,000 per employee per year. This is a credible purchase for an employer's wellness budget and eliminates consumer price sensitivity from the equation. The growth constraint: employer wellness budgets are cyclical and often the first thing cut in economic downturns.

The insurance integration model: Health insurers are increasingly willing to pay for engagement tools that improve outcomes and reduce claims. A diabetes management app that measurably reduces HbA1c in insured members is worth money to the insurer — fewer hospitalisation claims means real savings. Star Health, Aditya Birla Health Insurance, and Niva Bupa have all partnered with health apps on outcome-linked models where the healthtech earns revenue for measurably improving member health metrics. This is the highest-value model but requires clinical outcomes measurement infrastructure.

The government scheme model: ABHA (Ayushman Bharat Health Account) integration opens access to government healthcare beneficiaries. Ayushman Bharat PM-JAY covers 50 crore people. Health apps that build genuine integration with the public health infrastructure — telemedicine, ABDM-linked health records, referrals to empanelled hospitals — have access to scale that consumer apps cannot match.

Model 2: Transactional with Subscription Add-On

The most sustainable direct-to-consumer model is transactional first, subscription second. Lead with services that have immediate, clear value: online consultations (₹300-800 per consultation), lab test bookings with home collection (₹500-3,000 per order), medicine delivery (captured from the transaction margin). Build the subscription as a bundle of these services — "₹199/month unlocks unlimited GP consultations + 20% off labs" — so users can directly see the savings.

1mg executed this model well. They built a massive base on medicine delivery and lab test bookings — both transactional, high-frequency, clear-value services — before successfully pushing a subscription overlay (1mg Advantage). Users who had already experienced the value of the transactional services were far more likely to subscribe when offered a bundle.

Model 3: Chronic Condition Specialisation

Generic health apps struggle to monetise. Condition-specific apps for chronic conditions (diabetes, hypertension, PCOS, mental health) can command significantly higher willingness-to-pay because the stakes are higher and the value proposition is more specific. A diabetic who uses a monitoring app and achieves meaningful HbA1c improvement will pay ₹500-1,500/month — a consumer segment that won't pay for generic wellness will pay for demonstrated disease management.

BeatO (diabetes management) built a sustainable subscription business by combining a glucometer hardware purchase with ongoing app subscription — locking users into the ecosystem through device dependency while delivering genuine clinical value through coaching and monitoring. The hardware + subscription bundle is a proven model for condition-specific healthtech globally (Oura Ring, CGM subscriptions) and works in India where hardware purchase creates commitment.

Model 4: Diagnostics + Health Data Monetisation

Lab test aggregators (Healthians, Dr Lal PathLabs' digital channel, Thyrocare's digital layer) combine transactional revenue (lab test fees) with data network effects — a platform that has processed 10 million lab results has insights about population health trends that have genuine commercial value to insurers, pharma companies, and government health programs. This isn't a primary monetisation model for early-stage platforms, but it's a strategic moat for scaled platforms.

The Unit Economics Reality Check

Before choosing a monetisation model, understand the unit economics clearly. Consumer health subscription at ₹199-499/month requires customer acquisition costs below ₹1,500-2,000 to be profitable at 12-18 month payback — difficult in a paid-acquisition market. B2B2C corporate wellness at ₹2,000-4,000/employee/year with 500+ employee contracts has acquisition costs spread across a large block of users — the economics are far more favorable. Transactional telemedicine at ₹500/consultation requires 8-10 consultations per user per year to generate subscription-equivalent revenue — plausible for chronic condition patients, very difficult for the general wellness user who needs a doctor twice a year.

What's Coming: Insurance Linkage as the Monetisation Rail

The most interesting structural shift in Indian healthtech monetisation is the emerging connection between health behaviour data and insurance premiums. Aditya Birla Health Insurance's "Active Health" model — which adjusts premiums based on health activity tracking — is the earliest version of what will become a significant monetisation rail for health apps. Users who allow their health data to inform their insurance pricing get premium discounts; the health app earns revenue from the insurer for providing the data and engagement infrastructure. This model aligns everyone's incentives correctly and is likely to become a major monetisation pattern for health apps over the next 3-5 years.

FAQ

Should early-stage healthtech focus on consumer or B2B2C first?

B2B2C is almost always the better first focus for Indian healthtech. The reasons: faster revenue (one corporate deal = hundreds of users), more predictable cash flow, lower CAC, and a proof point that builds the credibility needed for consumer growth later. The consumer brand can be built on top of the B2B2C base — Practo, 1mg, and Mfine all have significant B2B2C revenue alongside their consumer businesses. Starting with consumer-first and hoping to pivot to B2B2C later is harder — enterprise sales requires relationship-building that takes time to develop.